We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M Turnover 60.61%
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
+$8.29M
Cap. Flow
+$2.99M
Cap. Flow %
4.5%
Top 10 Hldgs %
32.21%
Holding
297
New
108
Increased
49
Reduced
51
Closed
72
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$3.53M
2
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$2.94M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.18M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.54M
5
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.37M

Top Sells

Rank Stock Value
1
GIS icon
General Mills
GIS
+$2.52M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.31M
3
AMGN icon
Amgen
AMGN
+$2.08M
4
ABT icon
Abbott
ABT
+$1.72M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 43.45%
2 Miscellaneous 41.8%
3 Consumer Discretionary 7.1%
4 Consumer Staples 6.25%
5 Communication Services 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
A icon
226
PUT
Agilent Technologies
A
$47.9B
– –
-10,000
Closed -$13K –
ABT icon
227
CALL
Abbott
ABT
$180B
– –
-26,500
Closed -$417K –
AKBA icon
228
Akebia Therapeutics
AKBA
$188M
– –
-30
Closed -$461 –
ALNY icon
229
Alnylam Pharmaceuticals
ALNY
$31.2B
– –
-2,938
Closed -$251K –
AMGN icon
230
Amgen
AMGN
$230B
– –
-12,082
Closed -$2.08M –
AMGN icon
231
PUT
Amgen
AMGN
$230B
– –
-19,900
Closed -$60K –
BCRX icon
232
BioCryst Pharmaceuticals
BCRX
$2.06B
– –
-11,240
Closed -$62K –
BCRX icon
233
PUT
BioCryst Pharmaceuticals
BCRX
$2.06B
– –
-15,000
Closed -$38K –
BKD icon
234
CALL
Brookdale Senior Living
BKD
$2.35B
– –
-18,700
Closed -$7K –
BUD icon
235
CALL
AB InBev
BUD
$163B
– –
-5,000
Closed -$7K –
COST icon
236
CALL
Costco
COST
$441B
– –
-10,000
Closed -$6K –
COST icon
237
Costco
COST
$441B
– –
-2,300
Closed -$368K –
COST icon
238
PUT
Costco
COST
$441B
– –
-10,000
Closed -$16K –
CPB icon
239
CALL
Campbell Soup
CPB
$5.77B
– –
-17,600
Closed -$3K –
CPB icon
240
Campbell Soup
CPB
$5.77B
– –
-1,100
Closed -$57K –
CPB icon
241
PUT
Campbell Soup
CPB
$5.77B
– –
-10,000
Closed -$55K –
DBI icon
242
CALL
Designer Brands
DBI
$309M
– –
-20,000
Closed -$10K –
DIS icon
243
Walt Disney
DIS
$189B
– –
-5,000
Closed -$531K –
DIS icon
244
PUT
Walt Disney
DIS
$189B
– –
-5,000
Closed -$48K –
DVAX icon
245
DELISTED
Dynavax Technologies
DVAX
– –
-30,795
Closed -$487K –
DVAX icon
246
PUT
DELISTED
Dynavax Technologies
DVAX
– –
-83,600
Closed -$7K –
HOG icon
247
Harley-Davidson
HOG
$2.78B
– –
-2,954
Closed -$144K –
K icon
248
CALL
DELISTED
Kellanova
K
– –
-49,097
Closed -$9K –
KHC icon
249
CALL
The Kraft Heinz Company
KHC
$27.5B
– –
-45,100
Closed -$13K –
KPTI icon
250
CALL
Karyopharm Therapeutics
KPTI
$7.85M
– –
-8,413
Closed -$69K –
8 9
10
11 12

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2017 Portfolio in Review

As of Q3 2017, FT Options held 297 positions worth $66.4M, up 14% from $58.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FT Options deployed $2.99M of net new capital in Q3 2017, opening 108 new positions and adding to 49 existing holdings. Its largest new stake was Incyte: 27,887 shares worth $3.26M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was General Mills, an estimated $2.52M trimmed.

  • FT Options's largest Q3 2017 buy was Incyte: 27,887 shares worth $3.26M.
  • FT Options added most to Sio Gene Therapies Inc. Common Stock in Q3 2017, an estimated $1.37M increase.
  • FT Options's biggest Q3 2017 reduction was General Mills, cutting an estimated $2.52M.
  • FT Options fully exited Portola Pharmaceuticals, Inc. in Q3 2017, selling an estimated $2.31M.
  • FT Options's ten largest holdings make up 32% of its $66.4M portfolio in Q3 2017.
  • FT Options opened 108 new positions and closed 72 in Q3 2017.
  • FT Options's portfolio value rose 14% quarter-over-quarter to $66.4M.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.